EVOFEM BIOSCIENCES, INC. Cash and Cash Equivalents, Period Increase (Decrease)
EVOFEM BIOSCIENCES, INC. (EVFM) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$26.27 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-23.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-03-23
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was -$2.89M.
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was -$7.11M.
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-06-30 was -$2.62M.
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-03-31 was -$13.66M.
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$26.27M.
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$38.20M, a 153.36% decline from fiscal 2014.
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $71.58M.
- EVOFEM BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2013 was -$6.74M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -$9.99M derived: sum of 2 quarters · filed 2017-03-23 | -$12.61M derived: sum of 3 quarters · filed 2017-03-23 | -$26.27M 10-K · filed 2017-03-23 |
| 2016-09-30 | -$7.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$9.73M derived: sum of 2 quarters · filed 2016-11-10 | -$23.38M 10-Q · filed 2016-11-10 | -$36.91M derived: sum of 4 quarters · filed 2017-03-23 |
| 2016-06-30 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$16.28M 10-Q · filed 2016-08-11 | -$29.80M derived: sum of 3 quarters · filed 2017-03-23 | -$41.48M derived: sum of 4 quarters · filed 2017-03-23 |
| 2016-03-31 | -$13.66M 10-Q · filed 2016-05-12 | -$27.18M derived: sum of 2 quarters · filed 2017-03-23 | -$38.87M derived: sum of 3 quarters · filed 2017-03-23 | -$46.63M derived: sum of 4 quarters · filed 2017-03-23 |
| 2015-12-31 | -$13.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | -$25.21M derived: sum of 2 quarters · filed 2017-03-23 | -$32.97M derived: sum of 3 quarters · filed 2017-03-23 | -$38.20M 10-K · filed 2017-03-23 |
| 2015-09-30 | -$11.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$19.45M derived: sum of 2 quarters · filed 2016-11-10 | -$24.68M 10-Q · filed 2016-11-10 | $36.62M derived: sum of 4 quarters · filed 2017-03-23 |
| 2015-06-30 | -$7.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$12.99M 10-Q · filed 2016-08-11 | $48.30M derived: sum of 3 quarters · filed 2017-03-23 | $51.46M derived: sum of 4 quarters · filed 2017-03-23 |
| 2015-03-31 | -$5.23M 10-Q · filed 2016-05-12 | $56.07M derived: sum of 2 quarters · filed 2017-03-23 | $59.22M derived: sum of 3 quarters · filed 2017-03-23 | $61.22M derived: sum of 4 quarters · filed 2017-03-23 |
| 2014-12-31 | $61.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $64.45M derived: sum of 2 quarters · filed 2017-03-23 | $66.44M derived: sum of 3 quarters · filed 2017-03-23 | $71.58M 10-K · filed 2017-03-23 |
| 2014-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $5.15M derived: sum of 2 quarters · filed 2015-11-12 | $10.29M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $7.13M 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $5.14M 10-Q · filed 2015-05-14 | |||
| 2013-12-31 | -$6.74M 10-K · filed 2016-03-29 |